These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9666821)
1. Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease? Smith KJ; Barrett TL; Neafie R; Tomaszewski MM; Yeager J; Nelson A; Wagner KF; Skelton HG Br J Dermatol; 1998 May; 138(5):774-9. PubMed ID: 9666821 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy. Seitzer U; Scheel-Toellner D; Hahn M; Heinemann G; Mattern T; Flad HD; Gerdes J Adv Exp Med Biol; 1997; 421():217-21. PubMed ID: 9330700 [TBL] [Abstract][Full Text] [Related]
3. Lymphoid markers, activation markers, and adhesion molecules in cutaneous biopsy specimens from HIV+ patients with disease progression. The Military Medical Consortium for the Advancement of Retroviral Research. Smith KJ; Skelton HG; Yeager J; Baxter D; Nelson AT; Angritt P; Chu W; Wagner KF J Cutan Med Surg; 1998 Apr; 2(4):212-9. PubMed ID: 9558305 [TBL] [Abstract][Full Text] [Related]
4. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Del Prete G; Maggi E; Pizzolo G; Romagnani S Immunol Today; 1995 Feb; 16(2):76-80. PubMed ID: 7888070 [TBL] [Abstract][Full Text] [Related]
5. Role for CD30 antigen in human T helper 2-type responses. Romagnani S Ciba Found Symp; 1995; 195():55-62; discussion 62-7. PubMed ID: 8724830 [TBL] [Abstract][Full Text] [Related]
6. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281 [TBL] [Abstract][Full Text] [Related]
7. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. Bengtsson A; Johansson C; Linder MT; Halldén G; van der Ploeg I; Scheynius A J Leukoc Biol; 1995 Dec; 58(6):683-9. PubMed ID: 7499966 [TBL] [Abstract][Full Text] [Related]
8. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis. Becker Y Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648 [TBL] [Abstract][Full Text] [Related]
9. Crosslinking of CD30 on activated human Th clones enhances their cytokine production and downregulates the CD30 expression. Bengtsson A; Scheynius A; Avila-Cariño J Scand J Immunol; 2000 Dec; 52(6):595-601. PubMed ID: 11119266 [TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response. Rizzardi GP; Marriott JB; Cookson S; Lazzarin A; Dalgleish AG; Barcellini W Clin Exp Immunol; 1998 Oct; 114(1):61-5. PubMed ID: 9764604 [TBL] [Abstract][Full Text] [Related]
11. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Bengtsson A; Lundberg M; Avila-Cariño J; Jacobsson G; Holmgren A; Scheynius A Clin Exp Immunol; 2001 Mar; 123(3):350-60. PubMed ID: 11298119 [TBL] [Abstract][Full Text] [Related]
12. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010 [TBL] [Abstract][Full Text] [Related]
13. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Pellegrini P; Berghella AM; Contasta I; Adorno D Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032 [TBL] [Abstract][Full Text] [Related]
14. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. Manetti R; Annunziato F; Biagiotti R; Giudizi MG; Piccinni MP; Giannarini L; Sampognaro S; Parronchi P; Vinante F; Pizzolo G; Maggi E; Romagnani S J Exp Med; 1994 Dec; 180(6):2407-11. PubMed ID: 7964515 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells. Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534 [TBL] [Abstract][Full Text] [Related]
16. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020 [TBL] [Abstract][Full Text] [Related]
17. CD30 and type 2 T helper (Th2) responses. Romagnani S; Del Prete G; Maggi E; Chilosi M; Caligaris-Cappio F; Pizzolo G J Leukoc Biol; 1995 May; 57(5):726-30. PubMed ID: 7759952 [TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity among CD4+ T-cell clones from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2. Howe RC; Wondimu A; Demissee A; Frommel D Immunology; 1995 Apr; 84(4):585-94. PubMed ID: 7790032 [TBL] [Abstract][Full Text] [Related]
19. CD30 expression does not discriminate between human Th1- and Th2-type T cells. Hamann D; Hilkens CM; Grogan JL; Lens SM; Kapsenberg ML; Yazdanbakhsh M; van Lier RA J Immunol; 1996 Feb; 156(4):1387-91. PubMed ID: 8568238 [TBL] [Abstract][Full Text] [Related]
20. Role of TH1/TH2 cytokines in HIV infection. Romagnani S; Del Prete G; Manetti R; Ravina A; Annunziato F; De Carli M; Mazzetti M; Piccinni MP; D'Elios MM; Parronchi P Immunol Rev; 1994 Aug; 140():73-92. PubMed ID: 7821929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]